Status | Study |
Completed |
Study Name: Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients Condition: Opportunistic Infections Date: 2017-03-08 |
Not yet recruiting |
Study Name: Cryptococcal Antigen Screening Plus Sertraline Condition: Cryptococcosis Cryptococcal Infections AIDS-Related Date: 2016-12-14 Interventions: Drug: Sertraline sertraline 40 |
Recruiting |
Study Name: T Cell Therapy of Opportunistic Cytomegalovirus Infection Condition: Cytomegalovirus Infections Hematopoietic Stem Cell Transplant Date: 2016-12-02 Interventions: Biological: CMV specific adoptive t-cells It is expected that the cell dose will be in the range of 10^3 |
Recruiting |
Study Name: CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT Condition: Leukemia Lymphoma Myelodysplastic Syndromes Date: 2016-10-11 Interventions: Biological: CD45RA-depleted peripheral blood mononuclear cells Infusion of escalating doses of CD45RA-de |
Recruiting |
Study Name: Vicente Ferrer HIV Cohort Study Condition: HIV Tuberculosis Cryptococcosis Date: 2015-05-15 |
Recruiting |
Study Name: The Efficacy of Breathing Exercise With BreatheMAX Device on Airway Secretion Clearance and Lung Function Condition: Bronchial Secretion Retention Date: 2015-05-13 Interventions: Device: BreatheMAX (OPEP) for |
Recruiting |
Study Name: Cologne Cohort of Neutropenic Patients (CoCoNut) Condition: Hematological Malignancies Cancer Chemotherapy Date: 2013-03-19 Interventions: Drug: Antiinfectives To analyze to efficacy of (novel) drug therapies |
Completed |
Study Name: Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome Condition: Immune Reconstitution Inflammatory Syndrome Opportunistic Infections Date: 2012-03-16 |
Recruiting |
Study Name: A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes Condition: Anemia Intestinal Helminthiasis Intestinal Schistosomiasis Date: 2012-02-20 Interventions: Drug: Praziquantel and Albendazole |
Terminated |
Study Name: The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient Condition: Kidney Transplant Immunosuppression Date: 2011-08-24 Interventions: Drug: adjustment of immunosuppressant dosages |